We’re delighted to add a summary of the Australian VOXZOGO Early Experience Forum, which brought together experts in the field of achondroplasia to discuss early experiences with vosoritide.
These presentations covered unmet clinical needs, real-world evidence, long-term follow-up data, impact on quality of life, and ongoing research initiatives. They included presentations for a variety of specialists including Professor Ravi Savarirayan, Professor Klaus Mohnike, Tessa Dentry, Dr Penny Ireland and Tracy Tate.
Please login below to download this issue (PDF)